Financial Services and Healthcare Companies: Complementary Research on National Bank of Greece, Moneygram, Walker & Dunlop, Global Cash Access and PlasmaTech

NEW YORK, May 11, 2015 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.  

Moments ago, Analysts Review released new research updates concerning several important developing situations including National Bank of Greece S.A. (NYSE: NBG), Moneygram International Inc. (NASDAQ: MGI), Walker & Dunlop, Inc. (NYSE: WD), Global Cash Access Holdings, Inc. (NYSE: GCA), and PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

NBG Research Report: ( http://get.analystsreview.com/pdf/?c=National%20Bank%20of%20Greece&d=11-May-2015&s=NBG ),

MGI Research Report: ( http://get.analystsreview.com/pdf/?c=Moneygram%20International&d=11-May-2015&s=MGI ),

WD Research Report: ( http://get.analystsreview.com/pdf/?c=Walker%20%26%20Dunlop&d=11-May-2015&s=WD ),

GCA Research Report: ( http://get.analystsreview.com/pdf/?c=Global%20Cash%20Access&d=11-May-2015&s=GCA ).

PTBI Research Report: ( http://get.analystsreview.com/pdf/?c=PlasmaTech%20Biopharmaceuticals&d=11-May-2015&s=PTBI ),

============

--

Analyst Update: Divestment, Earnings Update, and Acquisition

U.S. stocks advanced sharply on Friday, after stronger employment data for April suggested the US economy is gaining traction again. The Dow Jones Industrial Average rose 1.49%, to close at 18,191.11, the S&P 500 gained 1.35%, to 2,116.10, and the NASDAQ Composite finished the session at 5,003.55, up 1.17%. European stocks rallied on Friday, lifted by the UK election results, which showed the Conservative Party unexpectedly sweeping into power again. Germany's DAX 30 rose 2.65%, France's CAC 40 advanced 2.48%, and the London's FTSE 100 closed 2.32% higher on Friday. Meanwhile, Asian markets surged on Friday after losing ground in the last few days. The Shanghai Composite, Japan's Nikkei, and Hong Kong's Hang Seng all posted gains on Friday.

Reuters reported on March 20, 2015 that National Bank of Greece (NBG) has postponed a share offering for Turkish unit Finansbank, because of fears that it would have raised a lower than expected sum. Under a restructuring plan approved by European regulators, NBG needs to sell 40% of its stake in Finansbank. NBG has been badly affected by Greece's debt crisis and recession.

On May 1, 2015, MoneyGram International reported its Q1 2015 financial results. Total revenue for the first quarter was $330.6 million, a decrease of 12% on a reported basis and 8% on a constant currency basis compared to the prior year. Investment revenue declined $4.3 million primarily due to one-time returns on legacy investments realized in the first quarter of last year.

On May 1, 2015, Walker & Dunlop, Inc. reported its Q1 2015 financial results. Net income during the quarter was $21.3 million, or $0.66 per diluted share, a 198% YoY increase from Q1 2014 net income of $7.1 million, or $0.21 per diluted share. Total revenues were $112.1 million for Q1 2015, a 73% increase over Q1 2014 revenue of $64.8 million.

Global Cash Access Holdings, Inc. announced its Q1 2015 financial results on May 5, 2015. Revenue rose by 38% YoY to $207.5 million in Q1 2015. Revenues included $55.1 million from the Games segment and a 1% YoY increase from the Payments segment. Operating income, inclusive of a $14.4 million benefit from one-time legal settlement proceeds, was $28.1 million, compared to $13.0 million in the same period last year.

On May 6, 2015, PlasmaTech Biopharmaceuticals, Inc. announced that it has entered into a definitive agreement to acquire Abeona Therapeutics. Abeona develops and commercializes therapies for patients with lysosomal storage diseases. Under the terms of the agreement, the Company will issue to Abeona Therapeutic members a total of 3,979,761 common shares upon closing of the transaction, and up to an additional $9 million in performance milestones, in common stock or cash, at the Company's option.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider, represented by a registered analyst has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review